三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
ALK-N001及其linker设计思路
ALK-N001及其linker设计思路
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:419KB
图片尺寸:1853*838
同报告图片
/
4
fCBBTEstTjAwMSDlj4rlhbYgbGlua2VyIOiuvuiuoeaAnei3ryB8IFBFR+mTvu+8iOiwg+iKguawtOa6tuaAp++8iSB8IEFBTu+8iOmFtuWIh+S9jeeCue+8iSB8IERYZCAocGF5bG9hZCkgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6ams5p2l6YWw5Lqa6IO677yI5L2T5YaF5pCt6L2m55m96JuL55m977yJIHwgIHwgIHwgIHwKCui1hOaWmeadpea6kO+8muOAiuiCv+eYpOW+rueOr+Wig+a/gOa0u+eahOiNr+eJqeWBtuiBlOeJqeWPiuaKl+S9k+iNr+eJqeWBtuiBlOeJqeOAi+WImOa6kOetie+8jOOAiuS4gOenjeiCv+eYpOmdtuWQkea/gOa0u+eahOmTguexu+WMlg==
所属报告:
昂利康-公司研究报告-主业有望企稳回升抗肿瘤创新药减毒增效平台或已得到验证-250721(34页).pdf
打包全文图表
相关数据
靶向ALK7的siRNA药物研发格局
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
收藏
竞争格局
2026-01-14
原图定位
查看详情
图29、依奉阿克与目内ALK抑制剂的
fCDoja/nianlkI3np7AgICB8IE9SUu+8iCXvvIkgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18Cnwg5L6d5aWJ6Zi/5YWLICAgfCA4MS43ICAgICB8Cnwg6Zi/5p2l5pu/5bC8ICAgfCA4Mi45ICAgICB8Cnwg5biD5qC85pu/5bC8ICAgfCA3NC4wICAgICB8Cnwg5oGp5rKZ5pu/5bC8ICAgfCA3NS4wICAgICB8Cnwg5aGe55Ge5pu/5bC8ICAgfCA2NS44ICAgICB8CgrotYTmlpnmnaXmupDvvJrlm73lrrbljLvkv53lsYDvvIzlhbTkuJror4HliLjnu4/mtY7kuI7ph5Hono3noJTnqbbpmaLmlbTnkIY=
收藏
行业数据
2025-08-19
原图定位
查看详情
图30、依奉阿克与目内ALK抑制剂的
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
收藏
行业数据
2025-08-19
原图定位
查看详情
ZG005-001项目患者基线(n,%)
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
收藏
行业数据
2025-07-15
原图定位
查看详情
ZG005-001项目不良反应(n,%)
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
收藏
行业数据
2025-07-15
原图定位
查看详情
中国临床肿瘤学会(CSCO)针对ALK(+)NSCLC的疗法推荐
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
收藏
行业数据
2025-06-19
原图定位
查看详情
ALK-TKI在我国的迭代发展历程
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
收藏
产业概述
2025-06-19
原图定位
查看详情
2018-2032E中国治疗NSCLC的ALK-TKI市场规模
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
收藏
市场规模
2025-06-19
原图定位
查看详情
2020-2024我国院内市场各款ALK-TKI产品竞争格局(按销售额计)
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
收藏
竞争格局
2025-06-19
原图定位
查看详情
百利天恒其他基于新一代linker-payload技术ADC药物布局及已开展临床研究
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
收藏
行业数据
2025-05-16
原图定位
查看详情
ALK-TKI一线疗效&安全性汇总(非头对头)
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
收藏
行业数据
2025-02-10
原图定位
查看详情
图表114中能建2023年电解槽集采标段一(ALK)中
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
收藏
行业数据
2024-12-13
原图定位
查看详情
图表113中能建2024年电解槽集采标段一(ALK)候
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
收藏
行业数据
2024-12-13
原图定位
查看详情
全球范围内共11款ROS1、ALK靶向药获批(截至2024.9.13)
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
收藏
行业数据
2024-09-14
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
莱古酶是一种更具有肿瘤组织特异性的酶,有望进一步提高安全性。Enhertu 的 linker包含四肽GGFG,该序列可被组织蛋白酶 B切割,从而释放游离化药。其 8个单药治疗试验综合分析了 879 名不同肿瘤类型患者,139 名(15.8%)患者已判定为发生间质性肺炎,这可能与组织蛋白酶 B非肿瘤高度特异性的表达有关。而 TMEA-SMDC 平台选用的莱古酶肿瘤组织特异性表现更好,该平台的小分子偶联新药莱古比星,通过其临床发现几百例病人采用新型化疗,没有发生间质性肺炎。莱古酶存在于细胞核内体/溶酶体系统中,并与细胞内蛋白质降解有关,但也在大多数肿瘤中过表达,包括乳腺癌、结肠癌、前列腺癌、中枢神经系统肿瘤等等,并分泌到肿瘤细胞表面和 TME 中。由于莱古酶在低 pH值(即 4.0-6.5)下具有活性,并且在生理中性 pH值下失活,因此它适合被设计用于在酸性 TME 和肿瘤细胞中激活的前药。
行业数据
原图定位
当前图表所属:
昂利康-公司研究报告-主业有望企稳回升抗肿瘤创新药减毒增效平台或已得到验证-250721(34页).pdf
公司2015-2025Q1归母净利润(亿元)及增速(%)
公司2015-2024分板块毛利率
公司2015-2024主营毛利拆分(亿元)
公司2015-2024主营收入拆分(亿元)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》